One cancer drug turned down after many years of research, but the company plans an appeal. The FDA continues to ask for substantial documentation in the hopes of better decision. Refusals don't help the cause when it comes to investors and the potential for continued research. Something...
Genetic markers making their way to electronic medical records with locating potential patients through medical records to perhaps identify candidates that would benefit. Cerner is one of the larger software companies used by many hospitals in the US. A genetic test that would allow identification...
This is an interesting opinion story from an individual that has a natural health site, which many have been criticized over the years as over talking what natural herbs and cures can product as far as results. This particular individual states only 1% of his entire site was related to cancer and...
This lends itself to an area whereby various area of cancer could be targeted, and with few or little side effect as the study states. The term "cellular immortality" is the term that describes cells that keep regenerating endlessly, like cancer cells do. It's a long way to...
You can set up a log in and donate today. Click here for details. As I had posted in a story a couple days ago, the bar has risen for venture capitalist investments, it is still there, but perhaps a little tougher to get, and with government cuts on grants and availability for research,...
Additional information is available at the website along with a listing of the peer committee. Over $350 million has been raised by the foundation. In addition to the Young Investigators awards the Challenge Awards were also recently in the news and announced. Online donations and subscriptions...
Patrice Milos, Vice President and Chief Scientific Officer, Helicos Biosciences This week I had the opportunity to talk with Patrice Milos from Helicos Biosciences who has a long background in global research and spent a number of years at Pfizer as Executive Director at Pfizer Global Research and Development...
It should be the discretion of individual physicians, not insurance companies or pharmacies, to substitute a branded biologic for a biosimilar, which goes back to putting the physician in the decision making process, not the non clinical analyzers. While the search for "cheap" continues...
Tumor Cell Profiling... the tests show if your cancer cells were killed by exposure to one or more of the 20 or so different anti-cancer drugs that might otherwise have been considered as possible treatments for your type of cancer. A test that can help determine which cancer drugs would appear...
If you use Outlook and a Tablet PC , this is a must have. I live in "Outlook" and downloaded and installed the software. I like it so much that I even put the software on my desktop IMAC running Vista, as a have a Wacom tablet that I use with my desktop computer. One...